Answers are grounded in this paper and cite their sources.
Introduction There is conflicting evidence on the benefits of parathyroidectomy (PTx) in reducing the incidence of cardiovascular disease (CVD) in patients with primary hyperparathyroidism (PHPT). Aim To perform a systematic review and meta-analysis to investigate the impact of PTx in PHPT on cardiovascular outcomes. Methods A systematic review was performed as per PRISMA guidelines. Pre- and post-operative data were expressed as continuous outcomes, reported as mean differences, and expressed with 95% confidence intervals following estimation using the Mantel-Haenszel method. Results In total, there were 16 studies included in the meta-analysis with a combined total of 796 patients. Fourteen studies were prospective, one was retrospective and one was a randomised control trial. This analysis found a significant reduction in SBP post-operatively (P = 0.003). The difference in DBP was NS (P = 0.050). Fasting blood glucose levels were also significantly reduced after surgery (P < 0.0001). Echocardiographic values showed that left ventricular mass index was not significantly reduced (P = 0.070) and left ventricular ejection fraction was not affected (P = 0.680). Cholesterol levels were not impacted by surgery. Conclusion This meta-analysis shows that PTx likely improves SBP and blood glucose levels in patients with PHPT. It is unclear if this in turn has any impact on long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Calpin et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: